1-92263708-T-TA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 16P and 1B. PVS1PP5_Very_StrongBS2_Supporting
The NM_053274.3(GLMN):c.1323_1324insT(p.Thr442TyrfsTer10) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,592,076 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000010 ( 0 hom. )
Consequence
GLMN
NM_053274.3 frameshift
NM_053274.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.42
Genes affected
GLMN (HGNC:14373): (glomulin, FKBP associated protein) This gene encodes a phosphorylated protein that is a member of a Skp1-Cullin-F-box-like complex. The protein is essential for normal development of the vasculature and mutations in this gene have been associated with glomuvenous malformations, also called glomangiomas. Multiple splice variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 15 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 1-92263708-T-TA is Pathogenic according to our data. Variant chr1-92263708-T-TA is described in ClinVar as [Likely_pathogenic]. Clinvar id is 660874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 21 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLMN | NM_053274.3 | c.1323_1324insT | p.Thr442TyrfsTer10 | frameshift_variant | 15/19 | ENST00000370360.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLMN | ENST00000370360.8 | c.1323_1324insT | p.Thr442TyrfsTer10 | frameshift_variant | 15/19 | 1 | NM_053274.3 | P1 | |
GLMN | ENST00000495106.5 | c.1238_1239insT | p.Leu413PhefsTer155 | frameshift_variant, NMD_transcript_variant | 14/18 | 1 | |||
GLMN | ENST00000463560.1 | c.586_587insT | p.Thr197TyrfsTer10 | frameshift_variant | 8/9 | 5 | |||
GLMN | ENST00000495852.6 | c.546_547insT | p.Thr183TyrfsTer10 | frameshift_variant | 7/10 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152228Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
21
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251422Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135882
GnomAD3 exomes
AF:
AC:
10
AN:
251422
Hom.:
AF XY:
AC XY:
4
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1439730Hom.: 0 Cov.: 26 AF XY: 0.00000836 AC XY: 6AN XY: 717832
GnomAD4 exome
AF:
AC:
15
AN:
1439730
Hom.:
Cov.:
26
AF XY:
AC XY:
6
AN XY:
717832
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74506
GnomAD4 genome
AF:
AC:
21
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
9
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Glomuvenous malformation Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center | Dec 30, 2022 | PVS1, PM2 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 18, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 25, 2018 | Loss-of-function variants in GLMN are known to be pathogenic (PMID: 23801931). This variant has been observed in an individual affected with vascular anomalies (PMID: 28655553). This variant is present in population databases (rs771252983, ExAC 0.06%). This sequence change creates a premature translational stop signal (p.Thr442Tyrfs*10) in the GLMN gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at